Reselute
PrivateLast Round
Seed Round
Jul 23, 2026
Total Funding Raised
$1.33M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Reselute operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Grant round in July 2024.
Reselute is a therapeutic devices company that develops solutions for the treatment of orthopedic-related infections.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reselute Comparables
Compare Reselute with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Johnson & Johnson | 78% | |
| Silver Bullet Therapeutics, Inc. | 78% | |
| OrthoXel | 77% |
For institutional investors. Book with your work email.
Reselute Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 23, 2026 | ||||
| Seed Round | May 29, 2025 | ||||
| Grant | Jul 15, 2024 | ||||
| Seed | May 18, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
Grant | May 5, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reselute Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| One North Carolina Small Business Program | Grant |
| Duke Capital Partners | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2026
$1M raised in Seed Round.
- May 29, 2025
Raised $2.39M in Seed funding.
For institutional investors. Book with your work email.
Reselute Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reselute's valuation, stock price, and market status.
Is Reselute a public or private company?
Reselute is a private company.
What is the current stock price of Reselute?
Reselute is a private company, so its shares have no public market price. Caplight tracks Reselute's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reselute worth (valuation)?
Valuation information for Reselute is not publicly available.
Can I buy Reselute stock?
Reselute shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reselute's last funding round?
Reselute's most recent funding round was Seed Round on July 23, 2026.
Who are the main investors in Reselute?
Key investors in Reselute include Duke Capital Partners.
Will Reselute IPO soon?
No public IPO plans have been announced for Reselute.
How can I track Reselute secondary market activity?
Caplight tracks bids, offers, and trades in Reselute's shares on secondary markets.